Rob Zenilman submits: Year over year annual revenue growth of stocks covered in the Biotech sector ranged from 88.7% (PGNX) down to -1.4% (MEDI), with a median value of 6.5%.
* View More Biotech Sector Charts *
Data in table version -- click on a ticker for
opinion and analysis of the company:
|
|
|
12 Mo.
|
Last
|
This
|
YOY
|
| Ticker
|
Company
|
Ending
|
Yr. $(mm)
|
Yr. ($mm)
|
Increase%
|
| AFFX | Affymetrix Inc. | 03/31/06 | $367.60 | $365.38 |
-0.6%
| | ALXN | Alexion Pharmaceuticals I | 03/31/06 | $1.21 | $1.41 |
16.8%
| | AMGN | Amgen Inc. | 03/31/06 | $12,022.00 | $12,414.00 |
3.3%
| | AMLN | Amylin Pharmaceuticals In | 03/31/06 | $140.47 | $218.56 |
55.6%
| | BIIB | Biogen Idec Inc. | 03/31/06 | $1,713.62 | $1,714.07 |
0.0%
| | BMRN | BioMarin Pharmaceutical I | 03/31/06 | $25.67 | $34.49 |
34.4%
| | BSTE | Biosite Incorporated | 03/31/06 | $287.70 | $295.19 |
2.6%
| | CELG | Celgene Corporation | 03/31/06 | $536.94 | $606.39 |
12.9%
| | DNA | Genentech Inc. | 03/31/06 | $6,633.37 | $7,157.37 |
7.9%
| | ELN | Elan Corp. plc | 03/31/06 | $490.30 | $521.90 |
6.4%
| | GILD | Gilead Sciences Inc. | 03/31/06 | $2,028.40 | $2,290.86 |
12.9%
| | GPRO | Gen-Probe Inc. | 03/31/06 | $305.97 | $323.39 |
5.7%
| | IMCL | Imclone Systems Inc. | 03/31/06 | $383.67 | $543.03 |
41.5%
| | INCY | Incyte Corp. | 03/31/06 | $7.85 | $11.40 |
45.2%
| | ISTA | ISTA Pharmaceuticals Inc. | 03/31/06 | $10.66 | $15.63 |
46.6%
| | KOSP | KOS Pharmaceuticals Inc. | 03/31/06 | $751.70 | $769.18 |
2.3%
| | MEDI | MedImmune Inc. | 03/31/06 | $1,221.00 | $1,203.90 |
-1.4%
| | NABI | Nabi Biopharmaceuticals | 04/01/06 | $108.06 | $109.53 |
1.4%
| | NBIX | Neurocrine Biosciences In | 03/31/06 | $101.89 | $102.26 |
0.4%
| | ONXX | Onyx Pharmaceuticals Inc. | 03/31/06 | $1.00 | N/A |
N/A
| | PGNX | Progenics Pharmaceuticals | 03/31/06 | $9.49 | $17.90 |
88.7%
| | PHRM | Pharmion Corp. | 03/31/06 | $221.24 | $226.10 |
2.2%
| | TELK | Telik Inc. | 03/31/06 | $0.02 | N/A |
N/A
| | VRTX | Vertex Pharmaceuticals In | 03/31/06 | $160.89 | $171.37 |
6.5%
|
Data: CapitalIQ
Note: Annual data is the most recently reported 12 months as of July 13, 2006 vs. the same period last year.
Related:
- Most recent opinion and analysis of Biotech stocks
-
Full transcripts of recent conference calls in the Biotech sector
-
Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a one-page recap of Jim Cramer's Mad Money TV show, Lightning Round, Radio program and Stop Trading?